Citi analyst Yigal Nochomovitz raised the price target on Arcus Biosciences (NYSE: RCUS) to $38.00 (from $36.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE